Company Performance Metrics
Meadow Tec is the UK’s leading researcher of cannabinoid-based medicines, treatments, and retail products. The members of the board and management are made up of seasoned consultants and industry executives, bringing their wealth of knowledge and experience to the company. R&D at Meadow Tec is working on producing the UK’s rarest cannabinoid
strains for medical use, and advancing cannabinoid technology by creating high-quality, reliable, and suitable products. The company seeks to develop ground-breaking new treatments for pain management, inflammation, cancer, skin conditions and more. The UK-based laboratory is performing innovative research into cannabinoids to deliver personalised treatment by combining cannabinoid compounds with individual user DNA. Meadow Tec will analyse the DNA of a user, and together with the help of a library of cannabinoid strains, determine the structure of compounds that will best treat the user’s ailments. Meadow Tec aspires to be a leading researcher and designer of strains for the global market. They aim to offer new medicines and solutions to achieve better health outcomes and higher quality of life. The vision of the company is to create a better everyday life for many people, and to provide improved health and medical benefits to all.
